409 related articles for article (PubMed ID: 19839765)
1. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
[TBL] [Abstract][Full Text] [Related]
2. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
[TBL] [Abstract][Full Text] [Related]
3. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.
Taniguchi R; Fukushima H; Osawa K; Maruyama T; Yasuda H; Weih F; Doi T; Maki K; Jimi E
J Biol Chem; 2014 Mar; 289(11):7349-61. PubMed ID: 24488495
[TBL] [Abstract][Full Text] [Related]
4. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
[TBL] [Abstract][Full Text] [Related]
5. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
Yilmaz ZB; Weih DS; Sivakumar V; Weih F
EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
[TBL] [Abstract][Full Text] [Related]
6. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
7. Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide.
Soysa NS; Alles N; Takahashi M; Aoki K; Ohya K
J Periodontal Res; 2011 Apr; 46(2):280-4. PubMed ID: 21348872
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
9. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB functions in osteoclasts.
Soysa NS; Alles N
Biochem Biophys Res Commun; 2009 Jan; 378(1):1-5. PubMed ID: 18992710
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
Souvannavong V; Saidji N; Chaby R
Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
[TBL] [Abstract][Full Text] [Related]
12. Constitutively active canonical NF-κB pathway induces severe bone loss in mice.
Otero JE; Chen T; Zhang K; Abu-Amer Y
PLoS One; 2012; 7(6):e38694. PubMed ID: 22685599
[TBL] [Abstract][Full Text] [Related]
13. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
Novack DV; Yin L; Hagen-Stapleton A; Schreiber RD; Goeddel DV; Ross FP; Teitelbaum SL
J Exp Med; 2003 Sep; 198(5):771-81. PubMed ID: 12939342
[TBL] [Abstract][Full Text] [Related]
14. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.
Zeng R; Faccio R; Novack DV
J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846
[TBL] [Abstract][Full Text] [Related]
15. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.
Vaira S; Johnson T; Hirbe AC; Alhawagri M; Anwisye I; Sammut B; O'Neal J; Zou W; Weilbaecher KN; Faccio R; Novack DV
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3897-902. PubMed ID: 18322009
[TBL] [Abstract][Full Text] [Related]
16. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
Dejardin E
Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
18. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.
Seo Y; Fukushima H; Maruyama T; Kuroishi KN; Osawa K; Nagano K; Aoki K; Weih F; Doi T; Zhang M; Ohya K; Katagiri T; Hosokawa R; Jimi E
Mol Endocrinol; 2012 Mar; 26(3):414-22. PubMed ID: 22282470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]